ProPhase Labs, Inc. (PRPH) Discusses Milestones in Most cancers Diagnostics, Genomics Enlargement, and COVID Accounts Receivable Assortment December 1, 2025 4:15 PM EST
Firm Contributors
Ted Karkus – Chairman & CEO
Presentation
Operator
Welcome, everybody. That is the ProPhase Labs Webinar. We’ll be getting began in 3 minutes at 1 / 4 after the hour. That is the ProPhase Labs Webinar with RedChip. We’ll be began.
Ted Karkus
Chairman & CEO
Ted Karkus right here, CEO of ProPhase Labs. How is that?
Operator
Thanks very a lot. Allow us to get began.
Hello. That is Craig with RedChip Corporations. Thanks for becoming a member of as we speak’s occasion with ProPhase Labs, which trades on the NASDAQ below the ticker PRPH. With us as we speak, we’ve Ted Karkus, the Chairman and CEO of ProPhase. We are going to start with a short presentation in a second, after which we are going to reply your questions. [Operator Instructions] Earlier than we start, please permit me to learn the secure harbor assertion. This name might comprise forward-looking statements throughout the which means of the Personal Securities Litigation Reform Act of 1995. All statements pertaining to future monetary and/or working outcomes together with different statements concerning the future expectations, beliefs, objectives, plans or prospects expressed by administration represent forward-looking statements. Any statements that aren’t historic reality also needs to be thought of forward-looking statements. In fact, forward-looking statements contain dangers and uncertainties. I now flip this webinar over to Ted. Please go forward.
Ted Karkus
Chairman & CEO
Nice. Thanks, Craig, and thanks all for becoming a member of. I’m going to imagine that almost all of you might be new to the story of ProPhase Labs and to me, that is the strategy I am going. I do different shows all year long normally month-to-month, the place it is principally for shareholders that know the corporate nicely. However the strategy I will take as we speak goes to be
